// App-Quantinova.ai

Filters

Biomarkers











Conference Name











Country

























Company

Search valid company name..

Conference Year













Drug











Disease











Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























3340 Abstracts

Autoimmune Polyglandular Syndrome II in a Patient with Takotsubo-s Cardiomyopathy

Karla Cristina Borromeo Detoya - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Dermatology

Heart muscle disease

Phosphatidylserine

Addisonian Crisis Presenting As Acute Ventricular Failure in the Postpartum

Yun Ying Shi - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

Fludrocortisone

Severe Hypercortisolism in Siadh

Sven Sufke - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

Hydrochlorothiazide

Sick Sinus Syndrome As First Manifestation of Pheochromocytoma : A Case Report

Jin Kyeong Shin - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Heart muscle disease

Catecholamine

Cushing-s Syndrome Related Dilated Cardiomyopathy: Favorable Outcome with Treatment

Rany Bassam Al-Agha - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

N/A

Functional and Structural Cardiac Abnormalities in Patients with Metastatic Pheochromocytomas and Paragangliomas

Vitaly Kantorovich - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Heart muscle disease

Catecholamine

Functional and Structural Cardiac Abnormalities in Patients with Metastatic Pheochromocytomas and Paragangliomas

Vitaly Kantorovich - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Heart muscle disease

Catecholamine

Multifactorial Severe Hypercalcemia in a Patient with Concomitant Sarcoidosis and Primary Hyperparathyroidism (HPT)

Jennifer Anna Burns Gibert - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Heart muscle disease

Calcitonin

Tauroursodeoxycholic Acid Attenuate Apoptosis Via Inhibition of Endoplasmic Reticulum Stress Against Diabetic Cardiomyopathy

Jiancheng Xu - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

Streptozotocin

Canagliflozin Associated Acute Renal Failure in a Patient with Stage II CKD and Compensated Heart Failure

Maria Javaid - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

Spironolactone

Recurrent Post-Heart Transplant Cardiomyopathy in a Patient with Undetected Growth Hormone Excess

Meltem Zeytinoglu - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

hGH

Acromegaly in a Patient with a Chromosome 1q43 Deletion

Jonathan Huang - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Heart muscle disease

hGH

Persistent Non-Ischemic Cardiomyopathy Induced By Panhypopituitarism Secondary to Sheehan Syndrome Following a Distant History of Severe Postpartum Hemorrhage

Nicolas Kissell - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

Heart muscle disease

Hydrocortisone

Founder Effect in Recurring AIP Mutation Causing Familial Isolated Pituitary Adenoma Syndrome

Roberto Salvatori - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

Mecasermin

Endocrine and Metabolic Characterization of Alstroem Syndrome

Daniela P Reyes-Capo - Endocrine Society (ENDO) , 2014

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Heart muscle disease

N/A

Prevalence and Risk Factors of Complications in Patients with Thalassemia Intermedia

Adisak Tantiworawit - American Society of Hematology (ASH) , 2014

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Heart muscle disease

N/A

A Human Bone Marrow Failure Syndrome Caused By a Homozygous Mutation in MYSM1

Ehsan Bahrami - American Society of Hematology (ASH) , 2015

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Heart muscle disease

Alemtuzumab

A novel pathway of biosynthesis of mammalian endogenous steroids: adrenocortical bufadienolide marinobufagenin starts from bile acids

Olga V. Fedorova - American Society of Hypertension (ASHy) , 2015

Therapeutic Area

Disease

Drug/Treatment

Obstetrics/Gynecology

Heart muscle disease

Danshen Dripping Pill

An IND-Enabling GLP-Toxicology and Biodistribution Study Assessing Systemic rAAV9-hNAGLU Gene Delivery for Treating MPS IIIB: Genotype- and Sex-Specific Dose-Limiting Acute Liver Toxicity in Male Wild Type C57BL/6 Mice

Haiyan Fu - American Society of Gene & Cell Therapy (ASGCT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

AAV Delivery of Tafazzin for the Correction of Mitochondrial Dysfunction in Barth Syndrome Using IPS Differentiated Cardiomyocytes

Amy L. Donate - American Society of Gene & Cell Therapy (ASGCT) , 2015

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Heart muscle disease

N/A

Copyright © 2026. QuantiNova All rights reserved